Infinity Pharmaceuticals reported $-12436000 in Pre-Tax Profit for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Abbvie ABBV:US $ 6567M 197M
Amgen AMGN:US $ 2727M 56M
Bristol Myers Squibb BMY:US $ 5386M 595M
Cytori Therapeutics CYTX:US $ -4.12M 0.04M
Eisai 4523:JP Y -20779M 34669M
Genocea Biosciences GNCA:US $ -15.98M 2.7M
Infinity Pharmaceuticals INFI:US $ -12.44M 0.78M
Johnson & Johnson JNJ:US $ 8218M 1879M
Mirati Therapeutics MRTX:US $ -188.39M 11.23M
Novartis NOVN:VX SF 3912M 230M
Pfizer PFE:US $ 11328M 4083M
Seattle Genetics SGEN:US $ -135.24M 41.73M
Tg Therapeutics TGTX:US $ -69.01M 24.32M
Vascular Biogenics VBLT:US -10428000 1.32M
YTE INCY:US $ 172.84M 1.75M